Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DXYN Stock Summary
In the News
DXYN Financial details
Company Rating
Buy
Market Cap
7.69M
Income
-2.51M
Revenue
276.34M
Book val./share
1.98
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
970
Optionable
No
Shortable
Yes
Earnings
02 May 2024
P/E
-0.44
Forward P/E
-
PEG
0.05
P/S
0.04
P/B
0.4
P/C
52.25
P/FCF
-2.85
Quick Ratio
0.63
Current Ratio
2.67
Debt / Equity
2.95
LT Debt / Equity
2.67
-
-
EPS (TTM)
-0.18
EPS next Y
-
EPS next Q
-
EPS this Y
-91.86%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-5.9%
Revenue Q/Q
-2.77%
EPS Q/Q
-231.25%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
26.61%
Inst Trans
0.76%
ROA
-12%
ROE
-81%
ROC
-0.09%
Gross Margin
23%
Oper. Margin
-5%
Profit Margin
-8%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.46-1.36
52W High
-
52W Low
-
RSI
46
Rel Volume
0.27
Avg Volume
53.17K
Volume
14.52K
Perf Week
-4.86%
Perf Month
-12.92%
Perf Quarter
-3.24%
Perf Half Y
-12.84%
-
-
-
-
Beta
2.338
-
-
Volatility
0.01%, 0.04%
Prev Close
1.48%
Price
0.5225
Change
-0.87%
DXYN Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-30
Metric | History | 2019-12-28 | 2020-12-26 | 2021-12-25 | 2022-12-31 | 2023-12-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 23.67 | 20.63 | 22.58 | 20.08 | 18.69 | |
Net income per share | 0.97 | -0.59 | 0.34 | -2.21 | -0.18 | |
Operating cash flow per share | 0.74 | 0.88 | -1.02 | -1.21 | 0.18 | |
Free cash flow per share | 0.47 | 0.77 | -1.31 | -1.52 | 0.11 | |
Cash per share | 0.05 | 0.13 | 0.1 | 0.02 | 0.01 | |
Book value per share | 4.63 | 4.16 | 4.39 | 2.08 | 1.98 | |
Tangible book value per share | 4.63 | 4.16 | 4.39 | 2.08 | 1.98 | |
Share holders equity per share | 4.63 | 4.16 | 4.39 | 2.08 | 1.98 | |
Interest debt per share | 7.59 | 6.97 | 6.95 | 8.35 | 6.34 | |
Market cap | 18.2M | 39.97M | 85.09M | 11.79M | 11.01M | |
Enterprise value | 131.07M | 138.94M | 183.9M | 132.31M | 123.45M | |
P/E ratio | 1.19 | -4.4 | 16.51 | -0.35 | -4.05 | |
Price to sales ratio | 0.05 | 0.13 | 0.25 | 0.04 | 0.04 | |
POCF ratio | 1.56 | 2.95 | -5.52 | -0.64 | 4.2 | |
PFCF ratio | 2.44 | 3.39 | -4.3 | -0.51 | 6.72 | |
P/B Ratio | 0.25 | 0.63 | 1.28 | 0.37 | 0.38 | |
PTB ratio | 0.25 | 0.63 | 1.28 | 0.37 | 0.38 | |
EV to sales | 0.35 | 0.44 | 0.54 | 0.44 | 0.45 | |
Enterprise value over EBITDA | 4.96 | 896.38 | 9.6 | -5.61 | 18.51 | |
EV to operating cash flow | 11.22 | 10.25 | -11.93 | -7.21 | 47.14 | |
EV to free cash flow | 17.59 | 11.79 | -9.3 | -5.77 | 75.32 | |
Earnings yield | 0.84 | -0.23 | 0.06 | -2.83 | -0.25 | |
Free cash flow yield | 0.41 | 0.29 | -0.23 | -1.94 | 0.15 | |
Debt to equity | 1.55 | 1.58 | 1.51 | 3.84 | 2.95 | |
Debt to assets | 0.46 | 0.43 | 0.43 | 0.6 | 0.45 | |
Net debt to EBITDA | 4.27 | 638.48 | 5.16 | -5.11 | 16.86 | |
Current ratio | 2.72 | 2.45 | 2.59 | 2.88 | 2.84 | |
Interest coverage | 2.33 | -1.83 | 2.11 | -4.41 | -0.06 | |
Income quality | 0.77 | -1.47 | -2.99 | 0.52 | -1.34 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.22 | 0.24 | 0.2 | 0.26 | 0.27 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.36 | -0.13 | 0.28 | 0.25 | -0.37 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.02 | 0 | |
Capex to depreciation | -0.37 | -0.16 | -0.52 | -0.6 | -0.14 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 10.02 | 7.46 | 5.8 | 10.18 | 2.86 | |
ROIC | 0.07 | -0.05 | 0.05 | -0.14 | 0 | |
Return on tangible assets | 0.06 | -0.04 | 0.02 | -0.16 | -0.01 | |
Graham Net | -6.2 | -6.28 | -6.36 | -7.31 | -7.37 | |
Working capital | 88.24M | 78.87M | 86.2M | 78.21M | 72.84M | |
Tangible asset value | 73.21M | 63.79M | 66.38M | 31.51M | 29.29M | |
Net current asset value | -34.85M | -35.75M | -28.71M | -51.55M | -52.5M | |
Invested capital | 1.55 | 1.58 | 1.51 | 3.84 | 2.95 | |
Average receivables | 39.84M | 37.43M | 39M | 32.65M | 24.35M | |
Average payables | 16.93M | 17.57M | 17.9M | 15.48M | 14.07M | |
Average inventory | 100.35M | 90.45M | 84.07M | 83.22M | 79.96M | |
Days sales outstanding | 36.19 | 43.57 | 43.1 | 30.07 | 31.28 | |
Days payables outstanding | 20.36 | 29.05 | 23.16 | 20.74 | 25.12 | |
Days of inventory on hand | 120.89 | 130.16 | 114.4 | 122.23 | 137.39 | |
Receivables turnover | 10.09 | 8.38 | 8.47 | 12.14 | 11.67 | |
Payables turnover | 17.93 | 12.57 | 15.76 | 17.6 | 14.53 | |
Inventory turnover | 3.02 | 2.8 | 3.19 | 2.99 | 2.66 | |
ROE | 0.21 | -0.14 | 0.08 | -1.06 | -0.09 | |
Capex per share | -0.27 | -0.11 | -0.29 | -0.3 | -0.07 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-30 for Q4
Metric | History | 2022-12-31 | 2023-04-01 | 2023-07-01 | 2023-09-30 | 2023-12-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.73 | 4.57 | 5 | 4.63 | 4.5 | |
Net income per share | -1.19 | -0.11 | -0.12 | -0.16 | 0.21 | |
Operating cash flow per share | -0.4 | -0.28 | 0.49 | 0.05 | -0.08 | |
Free cash flow per share | -0.45 | -0.3 | 0.47 | 0.03 | -0.1 | |
Cash per share | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 | |
Book value per share | 2.11 | 2.02 | 1.9 | 1.75 | 1.98 | |
Tangible book value per share | 2.11 | 2.02 | 1.9 | 1.75 | 1.98 | |
Share holders equity per share | 2.11 | 2.02 | 1.9 | 1.75 | 1.98 | |
Interest debt per share | 8.23 | 8.62 | 7.97 | 7.91 | 5.95 | |
Market cap | 11.63M | 11.15M | 19.69M | 10.21M | 11.04M | |
Enterprise value | 132.14M | 135.3M | 135.73M | 125.43M | 123.48M | |
P/E ratio | -0.16 | -1.8 | -2.85 | -1.07 | 0.87 | |
Price to sales ratio | 0.16 | 0.17 | 0.27 | 0.15 | 0.17 | |
POCF ratio | -1.93 | -2.75 | 2.72 | 15.02 | -8.79 | |
PFCF ratio | -1.75 | -2.52 | 2.81 | 19.87 | -7.5 | |
P/B Ratio | 0.37 | 0.38 | 0.7 | 0.39 | 0.38 | |
PTB ratio | 0.37 | 0.38 | 0.7 | 0.39 | 0.38 | |
EV to sales | 1.87 | 2.02 | 1.83 | 1.83 | 1.85 | |
Enterprise value over EBITDA | -10.82 | 98.76 | 56.7 | -56.73 | 343.01 | |
EV to operating cash flow | -21.88 | -33.33 | 18.71 | 184.46 | -98.39 | |
EV to free cash flow | -19.85 | -30.62 | 19.35 | 244.03 | -83.89 | |
Earnings yield | -1.52 | -0.14 | -0.09 | -0.23 | 0.29 | |
Free cash flow yield | -0.57 | -0.4 | 0.36 | 0.05 | -0.13 | |
Debt to equity | 3.84 | 4.2 | 4.13 | 4.45 | 2.95 | |
Debt to assets | 0.6 | 0.6 | 0.58 | 0.59 | 0.45 | |
Net debt to EBITDA | -9.87 | 90.62 | 48.47 | -52.11 | 312.35 | |
Current ratio | 2.88 | 2.92 | 2.63 | 2.67 | 2.84 | |
Interest coverage | -6.63 | -0.13 | 0.14 | -1.23 | -1.13 | |
Income quality | 0.31 | 2.62 | -4.48 | -0.31 | -0.37 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.31 | 0.25 | 0.26 | 0.27 | 0.3 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.1 | 0.09 | -0.03 | -0.24 | 0.17 | |
Capex to revenue | -0.01 | -0.01 | 0 | 0 | 0 | |
Capex to depreciation | -0.39 | -0.22 | -0.15 | -0.1 | -0.09 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 7.51 | 2.19 | 2.23 | 2.52 | 3.08 | |
ROIC | -0.07 | 0 | 0 | -0.01 | -0.01 | |
Return on tangible assets | -0.09 | -0.01 | -0.01 | -0.01 | 0.02 | |
Graham Net | -7.41 | -7.72 | -7.52 | -7.42 | -7.35 | |
Working capital | 78.21M | 83.98M | 75.89M | 75.53M | 72.84M | |
Tangible asset value | 31.51M | 29.71M | 28.15M | 25.93M | 29.29M | |
Net current asset value | -51.55M | -50.32M | -50.71M | -50.53M | -52.5M | |
Invested capital | 3.84 | 4.2 | 4.13 | 4.45 | 2.95 | |
Average receivables | 28.38M | 27.52M | 29.76M | 28.79M | 25.88M | |
Average payables | 16.83M | 15.58M | 18.23M | 19.21M | 16.42M | |
Average inventory | 88.8M | 83.68M | 81.42M | 79.56M | 78.08M | |
Days sales outstanding | 31.91 | 40.28 | 35.87 | 36.84 | 31.97 | |
Days payables outstanding | 21.07 | 30.98 | 32.39 | 33.81 | 25.78 | |
Days of inventory on hand | 124.14 | 152.86 | 131.41 | 142.92 | 141 | |
Receivables turnover | 2.82 | 2.23 | 2.51 | 2.44 | 2.81 | |
Payables turnover | 4.27 | 2.91 | 2.78 | 2.66 | 3.49 | |
Inventory turnover | 0.72 | 0.59 | 0.68 | 0.63 | 0.64 | |
ROE | -0.56 | -0.05 | -0.06 | -0.09 | 0.11 | |
Capex per share | -0.04 | -0.02 | -0.02 | -0.01 | -0.01 |
DXYN Frequently Asked Questions
What is The Dixie Group, Inc. stock symbol ?
The Dixie Group, Inc. is a US stock , located in Dalton of Ga and trading under the symbol DXYN
What is The Dixie Group, Inc. stock quote today ?
The Dixie Group, Inc. stock price is $0.5225 today.
Is The Dixie Group, Inc. stock public?
Yes, The Dixie Group, Inc. is a publicly traded company.